ArticleCancer management and research2018

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer.

Jiewei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.